Evidence map›Paper›PMID 17625227›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2007

Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice.

Esther J Kuiper, Peggy Roestenberg, Christoph Ehlken, Vincent Lambert, Henny Bloys van Treslong-de Groot, Karen M Lyons, Hans-Jürgen T Agostini, Jean-Marie Rakic, Ingeborg Klaassen, Cornelis J F Van Noorden and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2018
    Article
  4. Emerging roles of CCN proteins in vascular development and pathology.Journal of cell communication and signaling · 2016
    Article
  5. Retinal fibrosis in diabetic retinopathy.Experimental eye research · 2016
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Roles for CCN2 in normal physiological processes.Cellular and molecular life sciences : CMLS · 2011
    Review
  12. Article
  13. The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.Critical reviews in eukaryotic gene expression · 2011
    Review
  14. Article
  15. Temporal and spatial expression of CCN genes in zebrafish.Developmental dynamics : an official publication of the American Association of Anatomists · 2010
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Esther J KuiperOcular Angiogenesis Group, Department of Ophthalmology, Academic Medical Center, University of Amsterdam, The Netherlands.
Peggy Roestenberg
Christoph Ehlken
Vincent Lambert
Henny Bloys van Treslong-de Groot
Karen M Lyons
Hans-Jürgen T Agostini
Jean-Marie Rakic
Ingeborg Klaassen
Cornelis J F Van Noorden
Roel Goldschmeding
Reinier O Schlingemann
Academic Medical Center · NLUniversity Medical Center Utrecht · NLUniversity of Freiburg · DELeiden University Medical Center · NLUniversity of Amsterdam · NLUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Connective tissue growth factor (CTGF) is a member of the CCN family of growth factors. CTGF is important in scarring, wound healing, and fibrosis. It has also been implicated to play a role in angiogenesis, in addition to vascular endothelial growth factor (VEGF). In the eye, angiogenesis and subsequent fibrosis are the main causes of blindness in conditions such as diabetic retinopathy. We have applied three different models of angiogenesis to homozygous CTGF(-/-) and heterozygous CTGF(+/-) mice to establish involvement of CTGF in neovascularization. CTGF(-/-) mice die around birth. Therefore, embryonic CTGF(-/-), CTGF(+/-), and CTGF(+/+) bone explants were used to study in vitro angiogenesis, and neonatal and mature CTGF(+/-) and CTGF(+/+) mice were used in models of oxygen-induced retinopathy and laser-induced choroidal neovascularization. Angiogenesis in vitro was independent of the CTGF genotype in both the presence and the absence of VEGF. Oxygen-induced vascular pathology in the retina, as determined semi-quantitatively, and laser-induced choroidal neovascularization, as determined quantitatively, were also not affected by the CTGF genotype. Our data show that downregulation of CTGF levels does not affect neovascularization, indicating distinct roles of VEGF and CTGF in angiogenesis and fibrosis in eye conditions.

Indexed as

AnimalsAnimals, NewbornBone and BonesChoroidal NeovascularizationConnective Tissue Growth FactorEmbryo, MammalianImmediate-Early ProteinsIntercellular Signaling Peptides and ProteinsIn Vitro TechniquesLasersMiceMice, KnockoutNeovascularization, PathologicOxygenRetinal DiseasesVascular Endothelial Growth Factor ACCN2 protein, mouseConnective Tissue Growth FactorImmediate-Early ProteinsIntercellular Signaling Peptides and ProteinsOxygenVascular Endothelial Growth Factor A

Identifiers

PMID17625227
PMCPMC3957533
OpenAlexW2107131858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.